The role of p53 in radiation therapy outcomes for favorable-to-intermediate-risk prostate cancer (Q74292794)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12062599%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

The role of p53 in radiation therapy outcomes for favorable-to-intermediate-risk prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12062599%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

Mark A Ritter

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12062599%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Kennedy W Gilchrist

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12062599%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Marta Voytovich

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12062599%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Richard J Chappell

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12062599%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Bret M Verhoven

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12062599%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

language of work or name

English

0 references

publication date

1 July 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12062599%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Radiation Oncology Biology Physics

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12062599%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12062599%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12062599%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

574-580

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12062599%20AND%20SRC:MED&resulttype=core&format=json

Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902781-5

7 January 2021

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902781-5

7 January 2021

Conformal technique dose escalation for prostate cancer: Biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen ≥10 ng/ml

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902781-5

7 January 2021

External beam radiotherapy dose response of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902781-5

7 January 2021

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902781-5

7 January 2021

Radiotherapy for high grade clinically localized adenocarcinoma of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902781-5

7 January 2021

The importance of adequate follow-up in defining treatment success after external beam irradiation for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902781-5

7 January 2021

The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902781-5

7 January 2021

BCL-2 and p53 expression in clinically localized prostate cancer predicts response to external beam radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902781-5

7 January 2021

Locally recurrent prostate tumors following either radiation therapy or radical prostatectomy have changes in Ki-67 labeling index, p53 and bcl-2 immunoreactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902781-5

7 January 2021

bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902781-5

7 January 2021

p53 status and prognosis of locally advanced prostatic adenocarcinoma: a study based on RTOG 8610

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902781-5

7 January 2021

Correlation of genetic and immunodetection of TP53 mutations in malignant and benign prostate tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902781-5

7 January 2021

Role of p53 mutations in the radiosensitivity status of tumor cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902781-5

7 January 2021

Radiation-induced apoptosis in normal and pre-neoplastic mammary glands in vivo: significance of gland differentiation and p53 status

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902781-5

7 January 2021

Overexpression of bax sensitizes human breast cancer MCF-7 cells to radiation-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902781-5

7 January 2021

Inactivation of p53 and amplification of cyclin D1 correlate with clinical outcome in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902781-5

7 January 2021

Markers of radioresistance in squamous cell carcinomas of the head and neck: a clinicopathologic and immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902781-5

7 January 2021

p53 mutations associated with increased sensitivity to ionizing radiation in human head and neck cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902781-5

7 January 2021

Potential indicators of radiosensitivity in squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902781-5

7 January 2021

Adenoviral-mediated p53 transgene expression sensitizes both wild-type and null p53 prostate cancer cells in vitro to radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902781-5

7 January 2021

p53 and bcl-2 immunohistochemical alterations in prostate cancer treated with radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902781-5

7 January 2021

Predictive value of bcl-2 immunoreactivity in prostate cancer patients treated with radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902781-5

7 January 2021

p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902781-5

7 January 2021

Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902781-5

7 January 2021

Tumor suppressor p53 is a direct transcriptional activator of the human bax gene

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902781-5

7 January 2021

Relationship between p53 status and radiosensitivity in human tumour cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902781-5

7 January 2021

The prognostic significance of accumulation of p53 protein in stage III non-small cell lung cancer treated by radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902781-5

7 January 2021

Correlation between p53 gene expression and tumor-cell proliferation in oropharyngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902781-5

7 January 2021

10.1016/S0360-3016(02)02781-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12062599%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference